Uji klinis Migrain di Virginia
7 studi untuk Migrain mencari peserta di lokasi di Virginia.
Kota di Virginia
Teks studi resmi (Bahasa Inggris)
Study of EVO756 in Adults With Migraine
- MedStar Health: Headache Center at McLean, McLean
Menerima pesertaFase 2
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07616128Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
- dan 2 lainnya
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
- dan 2 lainnya
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT04649242Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Pediatric Associates of Charlottesville, PLC /ID# 230628, Charlottesville
- Children's Hospital of The King's Daughters - Children's Medical Tower /ID# 230581, Norfolk
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Health Research of Hampton Roads, Inc. (HRHR), Newport News
- AMR Clinical - Norfolk, Norfolk
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Children's Specialty Group - 3 Commercial Place, Norfolk
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT05164172Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
- MedStar Health: Neurology at McLean, McLean
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Des 2025 · NCT07301008Dari ClinicalTrials.gov, data diambil 4 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.